| Literature DB >> 22844436 |
Remko van Lutterveld1, Arjan Hillebrand, Kelly M J Diederen, Kirstin Daalman, René S Kahn, Cornelis J Stam, Iris E C Sommer.
Abstract
BACKGROUND: Auditory verbal hallucinations (AVH), a prominent symptom of schizophrenia, are often highly distressing for patients. Better understanding of the pathogenesis of hallucinations could increase therapeutic options. Magnetoencephalography (MEG) provides direct measures of neuronal activity and has an excellent temporal resolution, offering a unique opportunity to study AVH pathophysiology.Entities:
Mesh:
Year: 2012 PMID: 22844436 PMCID: PMC3402538 DOI: 10.1371/journal.pone.0041149
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient characteristics.
| Subject | Sex | Age (years) | Age of onset AVH (years) | Handedness | Psychiatric diagnosis | Antipsychotic medication/day |
| A | M | 41 | 21 | Right | paranoid schizophrenia | clozapine 300 mg and risperidone 3 mg |
| B | M | 36 | 34 | Right | paranoid schizophrenia | no antipsychotic medication |
| C | F | 52 | 19 | Right | psychosis NOS; borderline personality disorder | clozapine 600 mg |
| D | M | 39 | 19 | Right | paranoid schizophrenia | chlorprothixene 200 mg |
| E | M | 26 | 25 | Left | paranoid schizophrenia | flupenthixol 6 mg |
| F | F | 57 | 8 | Right | paranoid schizophrenia | no antipsychotic medication |
| G | M | 36 | 23 | Right | paranoid schizophrenia | clozapine 400 mg |
| H | M | 41 | 6 | Right | paranoid schizophrenia | clozapine 300 mg |
| I | M | 62 | 30 | Right | psychosis NOS | no antipsychotic medication |
| J | F | 57 | 9 | Right | paranoid schizophrenia | quetiapine 600 mg |
| K | M | 35 | 30 | Right | paranoid schizophrenia | no antipsychotic medication |
| L | F | 42 | 26 | Right | paranoid schizophrenia | olanzapine 10 mg |
AVH = auditory verbal hallucinations, M = male, F = female, NOS = not otherwise specified.
Figure 1Results for the AVH versus non-AVH analysis for the alpha and beta frequency bands.
Data are superimposed on a template brain and are presented in neurological convention (right is right). P<0.05, FWE corrected. The color bar indicates t-values.
Significantly activated voxels and locations of local maxima during auditory verbal hallucinations in the group hallucination task and button-press task.
| Task | Frequency band | Increase/decrease power | Lobe | Area | Montreal Neurological Institute Coordinates (x, y, z) | t | Cluster size |
| Hallucination task | Delta | - | |||||
| Theta | - | ||||||
| Alpha | Decrease | Right frontal | Inferior frontal gyrus | 48 21 15 | 4.88 | 36 | |
| Beta | Decrease | Left temporal | Superior temporal gyrus/Middle temporal gyrus | −60 −12 −12 | 4.04 | 48 | |
| Decrease | Left parietal | Supramarginal gyrus | −48 −33 33 | 4.00 | 12 | ||
| Button-press task | Delta | - | |||||
| Theta | - | ||||||
| Alpha | - | ||||||
| Beta | Decrease | Left parietal | Supramarginal gyrus/Postcentral gyrus | −42 −24 33 | 5.76 | 229 |
Figure 2Results for the AVH onset analysis superimposed on a template brain.
Data are presented in neurological convention (right is right). P<0.05, FWE corrected. The color bar indicates t-values.
Significantly activated voxels and locations of local maxima in the group hallucination onset analysis for the hallucination task and the control task.
| Task | Frequency band | Increase/decrease power | Lobe | Area | Montreal Neurological Institute Coordinates (x, y, z) | t | Cluster size |
| Hallucination task | Delta | - | |||||
| Theta | Decrease | Right temporal | Hippocampus/Amygdala | 30 −9 −12 | 3.93 | 28 | |
| Alpha | - | ||||||
| Beta | - | ||||||
| Button-press task | Delta | - | |||||
| Theta | - | ||||||
| Alpha | - | ||||||
| Beta | - |